Catheter Precision, Inc. 10-Q

ITEM 5. OTHER INFORMATION During the three months ended September 30, 2025 , no director or officer, as defined in Rule 16a - 1 (f) under the Securities Exchange Act of 1934, as amended, of the Company adopted or terminated a "Rule 10b5 - 1 trading arrangement" or "non-Rule 10b5 - 1 trading arrangement," as each term is defined in Item 408 (a) of Regulation S-K. On July 11, 2025, two short term promissory notes of $150 thousand each were issued by the Company’s majority-owned subsidiary KardioNav to David Jenkins, the Company's Chairman of the Board and Chief Executive Officer, and Lifestim, Inc., a company controlled by Mr. Jenkins, in exchange for an aggregate loan of $300 thousand. The promissory notes have a maturity date of July 11, 2026, and interest rates of 4.2% per annum, with all principal and interest payable upon maturity. As of September 30, 2025, $300 thousand of principal was outstanding on the notes. The notes, including all principal and interest, accelerate and become immediately due and payable upon the occurrence of certain customary events of default, including failure to pay amounts owed when due, material breach of the Company’s representations or warranties (unless waived by the holders or cured within 10 days following notice), certain events involving the discontinuation of the Company’s business and/or certain types of proceedings involving insolvency, bankruptcy, receivership and the like. 44 Table of Contents ITEM 6. EXHIBITS Exhibit Incorporated by Reference Number Description Form File No. Exhibit Filing Date 3.1.1 Amended and Restated Certificate of Incorporation of the Registrant. 8-K 001-38677 3.1 10/1/2018 3.1.2 Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant. (effective 11/16/20) 8-K 001-38677 3.1 11/17/2020 3.1.3 Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant. (effective 09/30/22) 8-K 001-38677 3.1 9/20/2022 3.1. 3A Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant. (filed 08/01/23, effective 08/17/23) 8-K 001-38677 3.1 8/4/2023 3.1. 3B Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant (filed 07/11/2024, effective 07/15/2024) 8-K 001-38677 3.1 7/12/2024 3.1.3C Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant (effective 1/13/2025) 10-K 001-38677 3.1 3/31/2025 3.1.3D Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant (effective 8/15/2025) 8-K 001-38677 3.1 8/15/2025 3.1.3E* Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant (effective 10/17/2025) 3.1.4 Certificate of Designation of Series X Convertible Preferred Stock. 8-K 001-38677 3.1 1/13/2023 3.1.5 Certificate of Designation of Series A Preferred Stock. 8-K 001-38677 3.2 1/13/2023 3.1.6 Certificate of Designation of Series B Preferred Stock. 8-K 001-38677 3.1 5/13/2025 3.2.1 Amended and Restated Bylaws of the Registrant. 8-K 001-38677 3.2 10/1/2018 3.2.2 Amendment to Amended and Restated Bylaws of the Registrant. 8-K 001-38677 3.1 8/17/2022 4.1 Specimen common stock certificate of the Registrant. S-1 333-226191 4.1 7/16/2018 45 Table of Contents 4.10 Form of Series B Warrant offered in February 2022. S-1/A 333-262195 4.9 2/3/2022 4.11 Form of Series C Warrant issued in July 2022 8-K 001-38677 4.1 7/22/2022 4.12 Warrant Agency Agreement, dated February 8, 2022, by and between the Registrant and American Stock & Trust Company LLC. 8-K 001-38677 4.4 2/9/2022 4.12.1 Amendment No. 1, dated July 22, 2022, to February 8, 2022 Warrant Agency Agreement by and between the Company and American Stock Transfer & Trust Company, LLC. 10-Q 001-38677 4.7 8/15/2022 4.17 Form of Series I common stock Warrant issued September 2024 8-K 001-38677 4.2 9/6/2024 4.18 Form of Series J common stock Warrant issued September 2024 8-K 001-38677 4.3 9/6/2024 4.20 Form of Series K Warrant issued October 2024 8-K 001-38677 4.1 10/25/2024 4.21 Form of Placement Agent Warrant offered in October 2024 8-K/A 001-38677 4.2 11/4/2024 4.22 Form of Underwriters' Warrant offered in September 2024 S-1 333-279930 4.17 6/26/2024 4.23 Form of Warrant Agency Agreement dated as of September 3, 2024 entered into by and between the Registrant and Equiniti Trust Company, LLC 8-K 001-38677 4.5 9/6/2024 4.24 Form of Series L Warrant offered in May 2025. 8-K 001-38677 4.1 5/13/2025 10.1* Short Term Promissory Note dated July 11, 2025 by and between KardioNav, Inc. and David A. Jenkins 10.2* Short Term Promissory Note dated July 11, 2025 by and between KardioNav, Inc. and Lifestim, Inc. 46 Table of Contents 31.1* Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 31.2* Certification of Principal Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 32.1*@ Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 32.2*@ Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 101.INS* Inline XBRL Instance Document 101.SCH* Inline XBRL Taxonomy Extension Schema Document 101.CAL* Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF* Inline XBRL Taxonomy Extension Definition Linkbase Document 101.LAB* Inline XBRL Taxonomy Extension Label Linkbase Document 101.PRE* Inline XBRL Taxonomy Extension Presentation Linkbase Document 104* Cover Page Interactive Data File (embedded within the Inline XBRL document). * Filed herewith. @ The information in this exhibit is furnished and deemed not filed with the Securities and Exchange Commission for purposes of section 18 of the Exchange Act of 1934, as amended (Exchange Act), and is not to be incorporated by reference into any filing of Catheter Precision, Inc. under the Securities Act of 1933, as amended (Securities Act), or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing. 47 Table of Contents SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. CATHETER PRECISION, INC. (Registrant) Date: November 13, 2025 By: /s/ David A. Jenkins David A. Jenkins Executive Chairman of the Board and Chief Executive Officer (Principal Executive Officer) Date: November 13, 2025 By: /s/ Philip Anderson Philip Anderson Chief Financial Officer (Principal Financial and Accounting Officer) 48